Manager, Analytical Engineer at Bristol-Myers Squibb

New Brunswick, New Jersey, United States

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

  • BA/BS or higher required (Computer Science, Physics, Math, Data Science, Pharmaceutical Science, or Engineering preferred)
  • 3 or more years' experience
  • Proficiency with SQL
  • Experience scripting (e.g. Python/R)
  • Experience with version control (e.g. Git, SVN) and Agile development
  • Proven analytical and problem-solving ability
  • Expertise gathering requirements to understand business needs and define technical solutions
  • Excellent communications and presentation skills (ability to explain complex analyses and outcomes to both technical and non-technical stakeholders)
  • Hands-on experience with dbt (a plus)
  • Familiarity with AI, ML, predictive modeling (a plus)
  • Knowledge of data engineering tools (Airflow) and visualization tools (Tableau, Power BI, Looker)
  • Familiarity with toolkit: work information process tools (JIRA, Confluence, ServiceNow, MS suites); data-related tools (Oracle, Redshift, PostgreSQL, CDP Impala, Athena)

Responsibilities

  • Collaborate with the business to gather requirements and deliver data-products to enable data-informed decision-making
  • As a member of the team, develop a centralized data-layer to deliver data-products at scale to the business
  • Use ELT framework to transform raw or semi-structured data into a contextualized data model, proposing architectural solutions to drive efficiency
  • Partner with AI and ML teams to deliver the data skeleton for AI-enabled internal tools
  • Work within dbt to deliver documented, tested, and DRY (“don’t-repeat-yourself”) code
  • Follow analytical lifecycle process and quality frameworks to deliver accurate data to internal consumers on-time
  • Focus on innovative solutions to increase speed-to-delivery and accelerate business decision-making

Skills

Analytics Engineering
Data Modeling
Data Pipelines
Data Transformation
ETL
SQL
Business Intelligence
Pipeline Optimization
Data Infrastructure

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI